| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2801982003014 | 198200301 | CISPLATIN/HOSPIRA SOL.INF 100MG/100ML VIAL ΒΤ x 1 VIAL x 100 ML | 24.89 | 26.11 | 35.98 |
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
Alkylating agents work by three different mechanisms: 1) attachment of alkyl groups to DNA bases, resulting in the DNA being fragmented by repair enzymes in their attempts to replace the alkylated bases, preventing DNA synthesis and RNA transcription from the affected DNA, 2) DNA damage via the formation of cross-links (bonds between atoms in the DNA) which prevents DNA from being separated for synthesis or transcription, and 3) the induction of mispairing of the nucleotides leading to mutations.
20-30 minutes
The parent compound, cisplatin, is excreted in the urine. Although small amounts of platinum are present in the bile and large intestine after administration of cisplatin, the fecal excretion of platinum appears to be insignificant.
* 15 - 16 L/h/m2 [After infusions of 100 mg/m2.]